Tamsulosin HCL 0.4 MG capsule 1000S
Ended Awarded Last action
- Contract number
- SPE2DR26FSXT3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,743
Award facts
- Contract value 100% obligated
- $2,742.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,742.96 to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly used to treat benign prostatic hyperplasia. The contract is a firm fixed-price delivery order with an ultimate completion date of January 8, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a relatively modest task order value within the pharmaceutical supply chain.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive pharmaceutical support vehicle supplying a broad range of medications, vaccines, and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor serving federal agencies including the Department of Defense, Department of Veterans Affairs, and other government healthcare systems. The company's federal procurement portfolio demonstrates extensive capability in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains for military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FSXT3?
SPE2DR26FSXT3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FSXT3 worth?
The government has obligated $2,743 on SPE2DR26FSXT3.
Is contract SPE2DR26FSXT3 an order under another contract?
Yes. SPE2DR26FSXT3 is a delivery order under SPE2DR25D1004, an indefinite delivery contract.
Was contract SPE2DR26FSXT3 competed?
The extent of competition for SPE2DR26FSXT3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award